Podcasts about Ras

Slovenský ženský hokej zažíva obrovský progres a ona patrí k našim najžiarivejším klenotom. Hokejistka roka 2024 Lucia Halušková momentálne oblieka dres elitného švajčiarskeho klubu HC Davos. Úspešná reprezentantka prijala pozvanie do videopodcastu suSPEAK na ŠPORT.sk, kde moderátorom Rasťovi Konečnému a Marekovi Marušiakovi s úsmevom porozprávala o tvrdých začiatkoch medzi chlapcami, švajčiarskej profesionalite i bláznivých posezónnych oslavách.Málokto o talentovanej útočníčke vie, že hokejovo vyrastala v Púchove výlučne v chlapčenskom kolektíve, kde pôsobila až do svojich tínedžerských rokov. V uvoľnenej debate priznáva, že hoci si musela úvodný rešpekt vybojovať a na štadióne sa delila o malú šatňu bez okien, chlapci ju nakoniec brali ako seberovnú a na ľade si ju ochranársky strážili.Diskusia sa prirodzene preklopila k jej aktuálnemu pôsobeniu pod Alpami. Prestížna švajčiarska liga priniesla nečakaný skok v profesionalite, od moderných analytických senzorov až po stretnutia s legendárnym Andresom Ambühlom. Samotný začiatok vo vysokej nadmorskej výške však nebol vôbec jednoduchý.„Prišla som tam, kondičná trénerka mi dala senzor a hneď som mala hodinu a pol v červenej zóne. Hovorila som si, že toto v živote absolútne nedám,“ spomína na kruté bežecké tréningy popri davoskej lanovke.Presah mimo športu ponúka diskusia o fungovaní mesta počas známeho Svetového ekonomického fóra. Extrémne bezpečnostné opatrenia zasahujú aj do bežného života hráčok, ktoré sa kvôli lukratívnym prenájmom musia na určitý čas zbaliť a dočasne vysťahovať zo svojich bytov.Zaujímavosťou je aj to, že domáce švajčiarske hokejistky vraj nie sú príliš zvyknuté na bujaré oslavy, čo im slovenská reprezentantka po konci sezóny rýchlo vysvetlila pri tanci na stoloch do štvrtej rána.Hoci vo Švajčiarsku našla špičkové zázemie, v kútiku duše už poškuľuje po najlepšej súťaži na svete. Novovzniknutá ženská obdoba zámorskej profiligy PWHL láka aj slovenskú reprezentantku. „Chcela by som tam ísť, uvidím, ako mi vyjde táto sezóna. Je to taký môj cieľ,“ potvrdila odhodlanie zabojovať o miestenku v PWHL.Najnovšia epizóda videopodcastu suSPEAK na ŠPORT.sk prináša mimoriadne pútavý, humorný a inšpiratívny pohľad do sveta ženského hokeja, o ktorom ste doteraz vedeli možno len málo. Pustite si celú epizódu a spoznajte osobnosť, ktorá robí Slovensku fantastické meno v zahraničí, a dozviete sa aj to, ako aktuálne vyzerá jej tvrdá letná príprava so slovenskými hokejistami.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Al-ḥamdu lillāhi Rabbil-‘Alāmīn. Wa salātu wa salāmu ‘alā sharaf al-anbiyā’i wa al-mursalīn, Muḥammadin Rasūlallāh, wa ‘alā ālihi wa sahbihi wa sallam. Tasliman kathīran kathīra. From my brother and sisters, we hear this āyah in every Jumu’ah. In the Qutbah, where Allāh SWT said: *Ya ayyuhal-ladhīna āmanū ittaqullāha haqqat-taqātihi*, wa la… Continue reading Khudrat of Allahﷻ

Part 2! Dr. Eric Jaffe returns to actually treat the cancer this time: why radiation is basically catching your kid smoking and making him finish the carton, how CRISPR turns your own T cells into an assassin squad, and why oncolytic viruses are just Jurassic World Dominion for tumors. Haven't heard Part 1 yet? Start there or you'll be lost. Mentioned: CAR-T therapy RAS inhibitor drugs Oncolytic viruses mRNA cancer vaccines Red Queen hypothesis Cancer-sniffing dogs Are you an expert in something and want to be on the show? Apply here! Please support the show on Patreon! You get ad-free episodes, early episodes, and other bonus content! https://www.patreon.com/seriouspod

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study BMJ Open This retrospective cohort study using target trial emulation evaluated the association between use of newer glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide, tirzepatide) and alcohol-related hospitalizations among adults with alcohol use disorder (AUD) and type 2 diabetes (T2D) or obesity. The authors found that among adults with AUD and T2D or obesity, initiation of newer GLP-1 RAs was associated with a lower observed risk of alcohol-related hospitalization.    Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Tapyba, tekstilė, fotografija, skulptūra, naujas požiūris į erdvę ir medžiagiškumą – penki menininkės Barbaros Kasten kūrybos dešimtmečiai pristatomi parodoje „Postabstrakcija“. Iš Kauno – Kotrynos Lingienės pasakojimas.Vilniaus miesto muziejuje atidaroma paroda „Gyvos Rasos“, skirta atskleisti 1801 metais įkurtų Rasų kapinių daugiasluoksniškumą.Pietų Korėjoje vyksta 48-oji UNESCO Pasaulio paveldo komiteto sesija. Lietuva joje prisistato kaip kandidatė į Pasaulio paveldo komitetą 2027–2031 metų kadencijai.Jonavoje šį savaitgalį vyks jubiliejinis, jau dešimtasis, sutartinių festivalis „Sutarysma“.Anykščių šilelyje įvyks Aleksandro Špilevojaus naktinio spektaklio-patyrimo „Pačios“, sukurto remiantis tikrais vietinių senolių pasakojimais, premjera.Sekmadienį Traupyje prasideda „Teatrono“ rezidencijų programa – pilotinis projektas, skirtas šiuolaikinio cirko menininkų susitikimams, kūrybiniams eksperimentams ir naujų darbų plėtojimui.Ved. Marius Eidukonis

CardioNerds (Drs. Apoorva Gangavelli, Jenna Skowronski, and Hannah Every) discuss the continuum of prevention and heart failure with Drs. Anu Lala and Martha Gulati. Grounded in a clinical case of a 55-year-old woman with uncontrolled hypertension, type 2 diabetes, and obesity who is on the trajectory toward heart failure, this episode unpacks a paradigm-shifting framework from a joint HFSA/ASPC Scientific Statement. The discussion explores how prevention should not be siloed from heart failure management but rather integrated across a patient’s lifespan—from primary prevention in at-risk individuals, to secondary prevention in those with established heart failure, to tertiary prevention in patients with advanced therapies such as LVADs and heart transplantation. The experts highlight the importance of aggressive risk factor management, biomarker-guided screening, the AHA’s Life’s Essential 8, and the need for multidisciplinary collaboration and systems-level change to shift heart failure care from reactive to proactive. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Systemic inflammatory diseases are associated with an elevated CVD risk that has significant implications for early detection, risk Heart failure prevention is a continuum, not a checkpoint. Prevention applies at every stage—from at-risk (Stage A) through advanced/post-transplant care—and every clinical encounter is an opportunity to intervene. The AHA’s Life’s Essential 8 (diet, physical activity, nicotine exposure, sleep, BMI, blood lipids, blood glucose, blood pressure) forms the foundation at every stage. Hypertension carries the highest population-attributable risk for heart failure of any modifiable risk factor. In the Framingham Heart Study, 91% of patients with newly diagnosed HF had pre-existing hypertension. The SPRINT trial demonstrated a 38% reduction in HF incidence with intensive blood pressure targets (30 ng/L or NT-proBNP >125 ng/L) identify individuals at heightened risk for progression to symptomatic HF. The ACC/AHA/HFSA guidelines give a Class IIa recommendation for natriuretic peptide screening in at-risk patients. Urine albumin-to-creatinine ratio (UACR) is an underutilized screening tool that provides additional insight into CKM risk. The heart failure label does not close the prevention window—it accentuates it. Secondary prevention through GDMT optimization (quadruple therapy in HFrEF) and continued risk factor management remains critical. Tertiary prevention extends to post-LVAD and post-transplant patients, where hypertension, diabetes, obesity, and CKD management remain essential to long-term outcomes. Show notes For a comprehensive review, please review the full HFSA/ASPC Joint Scientific Statement: Lala A, Beavers C, Blumer V, et al. The Continuum of Prevention and Heart Failure in Cardiovascular Medicine. J Card Fail. 2026;32:75-105. doi:10.1016/j.cardfail.2025.06.013 1. What is the “continuum of prevention” framework, and how does it differ from traditional approaches to heart failure prevention? Historically, prevention and heart failure management have been treated as separate disciplines—primary prevention handled by preventive cardiologists and treatment managed by heart failure specialists. This joint HFSA/ASPC Scientific Statement reframes prevention as a dynamic, continuous process that spans a patient’s entire lifespan, regardless of HF stage or ejection fraction. The framework maps onto the ACC/AHA HF staging system: Primary prevention targets Stage A (“at risk”) and Stage B (“pre-HF”) patients to reduce the burden of incident HF. Secondary prevention targets Stage C (symptomatic) and Stage D (advanced) patients to reduce the impact of established HF through GDMT optimization and ongoing risk factor management. Tertiary prevention encompasses risk factor management in patients with LVADs or heart transplants—populations where hypertension, diabetes, and obesity still drive outcomes. The Central Figure of the statement illustrates that Life’s Essential 8 (blood pressure and lipid control, diabetes management, exercise, sleep, smoking cessation, weight management, and diet/nutrition counseling) forms the foundation at every stage, with pharmacologic and device-based therapies layered on top as disease progresses (Figure) 2. How do traditional risk factors drive heart failure, and what should clinicians prioritize? Hypertension carries the greatest population-attributable risk for HF. In the Framingham Heart Study (N=5,143), HTN was associated with a 2- to 3-fold increased risk of HF, with a population-attributable risk of 39% in men and 59% in women. The SPRINT trial showed a 38% reduction in HF incidence and 25% reduction in the primary composite outcome with intensive BP targets (30 ng/L or NT-proBNP >125 ng/L) are associated with heightened risk for progression to symptomatic HF. In the ARIC study, incorporating NT-proBNP reclassified 20% of older adults without HF into Stage B. Factors that affect interpretation include age, sex, obesity (lower values), and CKD (higher values). High-sensitivity cardiac troponin (hs-cTn): Concentrations above the 99th percentile are now included in the definition of Stage B HF. Troponin testing may complement natriuretic peptides, particularly when BNP/NT-proBNP values are ambiguous. Risk scores: The PCP-HF equation predicts 10-year HF risk using traditional risk factors plus QRS duration. The AHA PREVENT score incorporates HF risk calculation and includes markers of kidney function (albuminuria, eGFR), though it may underestimate risk in men and Black adults. The CKM syndrome staging framework (Stages 0–4) provides a holistic approach to assessing systemic cardiovascular-kidney-metabolic risk. 4. What are the key nontraditional risk factors and cross-cutting themes in heart failure prevention? Genetics: Pathogenic cardiomyopathy variants exist in ~1 in 200 individuals in the general population. The HFSA and ACMG recommend cascade testing to identify at-risk family members. Polygenic risk scores for dilated cardiomyopathy show a 3.8-fold risk for DCM in the top 10th percentile compared with the median. Sex-specific considerations: Women have 2.8 times the odds of developing HFpEF, while men have similarly increased odds of HFrEF. A complete obstetric/gynecologic history is essential—preeclampsia is associated with a 4-fold increased risk of HF. Peripartum cardiomyopathy requires intentional screening in high-risk populations. Cardiotoxic exposures: Clinicians should be aware of medications that cause direct myocardial toxicity (e.g., anthracyclines, trastuzumab, tyrosine kinase inhibitors). A team-based approach with pharmacists can help optimize medication selection and risk factor modification. Social determinants of health: Environmental exposures (air pollution, arsenic, lead, cadmium), food insecurity, financial instability, and limited healthcare access contribute to HF risk and progression. Equity-focused, risk-based prevention strategies are needed. Psychological health: Depression is common in HF and independently associated with worse outcomes. Screening with brief questionnaires (e.g., PHQ-2) is recommended. Meditation, spirituality, and holistic wellness approaches remain underutilized. 5. What systems-level and policy changes are needed to move the needle on heart failure prevention? Multidisciplinary HF prevention clinics that bring together preventive cardiologists, HF specialists, endocrinologists, nephrologists, dietitians, pharmacists, exercise physiologists, and genetic counselors are advocated by the statement. EHR-embedded risk stratification could proactively flag patients on a trajectory toward HF—analogous to sepsis alerts or fall risk flags—enabling earlier intervention, particularly for patients who may not reach a cardiologist. Cardiac rehabilitation remains underutilized, particularly in HFrEF (Class 2b recommendation) and HFpEF (not yet covered by Medicare). The HF-ACTION trial showed quality-of-life benefits, and the REHAB-HF trial showed particular benefit in older patients with HFpEF. Policy priorities include expanding insurance coverage for preventive screening and novel therapies (SGLT2i, GLP-1 RAs, nsMRAs), reducing clinical inertia through team-based care models with closer follow-up intervals, and ensuring equitable access to evidence-based therapies across diverse populations. Digital health and AI hold promise for personalized risk prediction, remote monitoring (e.g., wearable devices, implantable PA pressure monitors), and virtual cardiac rehabilitation to overcome access barriers. Figure  Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013) References Key references are bolded. Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013 Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063 Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-e43. doi:10.1161/CIR.0000000000001078 SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-2116. doi:10.1056/NEJMoa1511939 Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-1562. doi:10.1001/jama.1996.03530440037034 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981 Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. doi:10.1056/NEJM200001203420301 Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa1504720 Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa2107038 Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-1098. doi:10.1056/NEJMoa2206286 Filippatos G, Anker SD, Agarwal R, et al. Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial. Circulation. 2022;145(6):437-447. doi:10.1161/CIRCULATIONAHA.121.057983 Solomon SD, McMurray JJV, Vaduganathan M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2024;391(16):1475-1485. doi:10.1056/NEJMoa2407107 Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563 Deanfield J, Verma S, Scirica BM, et al. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. 2024;404(10454):773-786. doi:10.1016/S0140-6736(24)01498-3  Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. doi:10.1056/NEJMoa2306963 Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636-1664. doi:10.1161/CIR.0000000000001175 Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation. 2024;149(6):430-449. doi:10.1161/CIRCULATIONAHA.123.067626 Khan SS, Ning H, Shah SJ, et al. 10-year risk equations for incident heart failure in the general population. J Am Coll Cardiol. 2019;73(19):2388-2397. doi:10.1016/j.jacc.2019.02.057 Bozkurt B, Fonarow GC, Goldberg LR, et al. Cardiac rehabilitation for patients with heart failure: JACC expert panel. J Am Coll Cardiol. 2021;77(11):1454-1469. doi:10.1016/j.jacc.2021.01.030 Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018;137(15):1614-1631. doi:10.1161/CIRCULATIONAHA.117.032474 Lala A, Tayal U, Hamo CE, et al. Sex differences in heart failure. J Card Fail. 2022;28(3):477-498. doi:10.1016/j.cardfail.2021.10.006 Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure. Eur J Heart Fail. 2021;23(3):352-380. doi:10.1002/ejhf.2115 Hershberger RE, Givertz MM, Ho CY, et al. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2018;24(5):281-302. doi:10.1016/j.cardfail.2018.03.004 Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association. Circulation. 2021;143(10):e763-e783. doi:10.1161/CIR.0000000000000947 Ezekowitz JA, Colin-Ramirez E, Ross H, et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022;399(10333):1391-1400. doi:10.1016/S0140-6736(22)00369-5

Rob van de Ven, managing director of Landing Aquaculture, discusses his extensive experience in the RAS industry, emphasizing innovation and tackling challenging projects. He highlighted the importance of tailoring RAS systems to specific species. He stressed the need for standardization while maintaining flexibility, especially for new species.

In this episode of Roompact's ResEdChat, join our host Noah Montague and guest  Siobhàn Anderson-Judkins as they talk about student staff supervision. Student staff, RAs, or whatever other acronym your institution uses are all coming into the role for different reasons; so how can we best supervise them? How do we hold them accountable while also being...... Continue Reading →

In this episode, host Ken Vinacco is joined by CSM 2026 DD SIG Platform Award winner Franchino Porciuncula. They discuss this study on use of RAS for improving gait automaticity in people with PD. In this study, Dr. Porciuncula explored the possible mechanisms by which RAS works. We also learn more about FNIRS technology for mobile brain imaging. Ever wondered what's going on in the brain when you turn on your metronome in the clinic? This one's for you!  For questions about this podcast, please contact neuroddsig@gmail.com.  Show notes available here

It's claimed enhancements to the Tenant In-Situ Scheme would have a major impact on Clare's homeless crisis. At present, the local authority can only purchase a home to re-rent to a tenant whose been served a notice to quit if their in receipt of HAP or RAS or if the property has been in the social housing support system for at least 2 years. In 2025 alone, Clare County Council drew down less than half of the €4m available to it under the Tenant In-Situ scheme. Mayor of Ennis, Clarecastle Sinn Féin Councillor Tommy Guilfoyle says it's not fit for purpose.

https://youtu.be/51vnmlgMm1s Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm, Alhamdulillāhi Rabbil ‘Alāmīn, wa salātu wa salāmu ‘alā ash-sharafī al-anbiyā’ wal-mursalīn, Muḥammadur Rasūlullāh ﷺ, tasliman kathīran kathīran. From my brothers and sisters, I have a formula that I call my formula for da’wah. And the formula is, Iqra, Qum, Qum. Now, I’ll tell you, in a minute I’ll tell… Continue reading Da’awa – 2

Nekompromisný obranca počas svojej bohatej kariéry prešiel desiatkami klubov, jeho životný príbeh je však ešte pestrejší. Lukáš Kozák je nielen skúseným hokejistom s blížiacou sa métou 700 zápasov v extralige, ale aj mládežníckym majstrom Slovenska v džude a úspešným podnikateľom. Teraz prijal pozvanie do podcastu suSPEAK na ŠPORT.sk, kde moderátorom Rasťovi Konečnému a Marekovi Marušiakovi úprimne porozprával o realite domáceho hokeja či budovaní biznisu na Jadrane.Málokto o rodákovi z Martina vie, že kým sa definitívne zasvätil najrýchlejšej kolektívnej hre na svete, patril medzi obrovské talenty na tatami. Džudu sa venoval do 15 rokov a z tohto obdobia si odniesol nielen majstrovské tituly, ale predovšetkým výbornú obratnosť a flexibilitu, z ktorých fyzicky čerpal počas celej hokejovej kariéry. V uvoľnenej debate priznáva, že na ľad ho pôvodne vôbec neťahalo a prvé tréningy absolvoval len vďaka susedovi, no napokon mu vôňa kabíny prirástla k srdcu.Diskusia sa prirodzene preklopila aj k náročným témam a fungovaniu profesionálneho hokeja na Slovensku. Skúsený obranca, ktorý pôsobil v Slovane Bratislava, Skalici, Prešove či naposledy v Liptovskom Mikuláši, kriticky zhodnotil najmä prístup vedenia a trénerov k mladým hráčom, pričom poukázal na absurdné vyhrážky v šatniach a chýbajúci elementárny rešpekt.„Vždy sa pri problémoch vrátime iba k financiám, ale to najmenej, čo by sa mohlo ihneď zlepšiť a nestojí to vôbec nič, sú medziľudské vzťahy v kluboch,“ zamýšľa sa nad toxickým prostredím, ktoré často dehonestuje začínajúcich hokejistov.Keďže v minulosti tvoril pár so známou influencerkou Nelou Slovákovou, nevyhol sa ani enormnému tlaku bulvárnych médií, ktoré pravidelne rozoberali jeho súkromie. Túto životnú kapitolu dnes vníma ako cennú, no veľmi nepríjemnú lekciu. Otvorene opisuje, že neustále vysvetľovanie skreslených titulkov ho naučilo prísne si chrániť svoj osobný život, pričom sociálne siete už vníma vyslovene len ako nutný pracovný nástroj, od ktorého si rád drží zdravý odstup.Dôležitý presah mimo športu ponúka jeho podnikateľský príbeh z chorvátskej Rogoznice, kde vybudoval a spravuje úspešný komplex apartmánov. K nehnuteľnostiam prišiel počas pandemickej krízy a vďaka skúsenostiam z rodinnej stavebnej firmy sa sám pustil do rozsiahlej rekonštrukcie bezprostredne po vypadnutí z play-off. „Urobili sme to od piky, že tam pomaly ostali stáť len oporné múry, no pri prácach som sa toho neskutočne veľa naučil,“ približuje moderátorom zrod svojho letného biznisu, ktorý dnes funguje už celoročne.Hoci má hokejovú kariéru stále aktívne rozbehnutú, život po jej definitívnom ukončení si vie predstaviť práve na slnečnom pobreží Jadranu, ktoré vníma ako mimoriadne bezpečné a ideálne miesto pre výchovu detí. Divákom detailne opisuje aj to, ako do apartmánového biznisu reálne zasiahlo prijatie eura či nové dane, no zároveň vyvracia mýty o extrémnej drahote, pokiaľ človek pozná lokálne pomery a vyhne sa najexponovanejším turistickým pasciam.Najnovšia epizóda podcastu suSPEAK na ŠPORT.sk prináša mimoriadne pútavý, humorný a inšpiratívny pohľad do sveta športu, o ktorom ste možno doteraz vedeli len málo. Pustite si celú epizódu a spoznajte osobnosť, ktorá dokazuje, že slovenský hokejista vie nielen tvrdo pracovať na ľade, ale dokáže aj úspešne a s prehľadom riadiť vlastný biznis.

You have read the books. You've done the retreats. You have overhauled your diet, your sleep, your morning routine. And you still feel the gap. Not broken, not lazy. Just caught in a loop that the next fix never quite closes. We want to talk about why.This episode is about the biology of being stuck. Not the shame of it. The actual mechanism. We get into what is really happening inside a nervous system that has been running on chronic stress, why the search for the next solution is neurologically wired into that state, and what it actually takes to interrupt the cycle for good. We cover the 90-second chemistry of emotion, Hebb's Law, the reticular activating system, Viktor Frankl's stimulus-response space, and the neuroscience of mental rehearsal. This one is about giving you a real explanation for what has felt personal, and a real path forward.What You'll Learn:Why your body can become physiologically addicted to stress hormones, and how that keeps you unconsciously generating the exact conditions you are trying to escapeThe 90-second rule: what Dr. Jill Bolte Taylor's neuroanatomy research reveals about how long an emotion actually lasts in the body, and what everything after that meansWhy insight alone cannot change your nervous system, and what your nervous system actually responds toHow Hebb's Law works in your favor: every time you practice a new emotional state, you are building real, measurable neural architectureWhat the reticular activating system (RAS) is doing with your beliefs, and how shifting that filter changes what you are available to see and act onViktor Frankl's "space between stimulus and response," and why every external fix misses it entirelyWhat mental rehearsal actually is neurologically, and how elite athletes have used it for decades to become familiar with a state before they are living itThe identity question that changes everything: who do I need to decide I am for this to become true?Your Next StepsFollow us on Instagram: https://www.instagram.com/eversiowellness/Shop Eversio Wellness and save 15% with code PODCAST15: https://www.eversiowellness.com/discount/PODCAST15?redirect=%2Fcollections%2Fall-productsTake our wellness QUIZ to find the right mushroom for you: https://www.eversiowellness.com/pages/take-our-quiz

Why You’re Suddenly Noticing Small Signs the Universe Has Your Back Tiny miracles are the small, easy-to-miss moments of grace that show up in an ordinary day. This might include a stranger’s kindness, a found coin, a text that arrives at exactly the right moment. Noticing them changes how supported life feels, even though nothing about your circumstances has actually changed. I didn’t go looking for this. It started with a compliment from a stranger, then a quarter on the ground, then a phone call I’d been hoping for. None of it was earth-shattering on its own. But the moments kept stacking up, one after another, until I couldn’t ignore the pattern anymore. Which made me wonder if these tiny miracles been happening all along, and was I too busy or too in my head to catch them? What Counts as a Tiny Miracle? A tiny miracle is any small moment of unexpected kindness, timing, or connection that feels like more than coincidence. It doesn’t need to be dramatic. Here’s what showed up for me in just a few weeks once I started paying attention: A stranger’s kindness at the grocery store. The produce person complimented my black-and-brown dress, then struck up a whole conversation about her love of neutral colors. Kindness with shopping carts. At one store, a man wheeling his cart toward the entrance handed it to me and went back for another. Days later at Trader Joe’s, a woman did the same thing at the front door. Then, when I finished unloading the cart into my car, an employee took the cart away without a word. I was taken care of from door to door! Found money. I found a quarter in the parking lot when visiting the chiropractor. Finding change always feels a little magical to me. A message from a flower. I was in the garden and felt the nudge to photograph a vine with small purple flowers and yellow stamens. I asked if it had a message for me and heard that it was looking forward to serving the bees. Then bam, a bee landed on the flower right after, so I caught that shot too. An invitation. I’d been wondering when he’d invite my husband and me on our annual boat ride. He called two days later with the invitation. My husband cleaned up the deck. Getting ready for dinner out one evening, I came downstairs to find the outdoor cushions already brought in and the table umbrella closed.  This is something I usually have to ask for. It’s not that he doesn’t take initiative. It’s just never been about the deck. I didn’t win the lottery. No angels showed up. Nothing huge happened. And yet every single one of these tiny miracles made me smile. Why Did These Small Moments Affect Me So Much? Small moments like these affect us because most of us move through the day too fast to allow them to register. We’re checking off errands, replaying conversations, or worrying about what’s next. In the process we miss the majority of the good things happening all around us. Take a minute to ask yourself honestly. Did someone smile at you today? Did someone let you merge in traffic, or did you grab the last package of pre-sliced turkey at the deli counter? Chances are a few of these already happened and slid right past you. It’s not that the Universe decided to start sending me tiny miracles out of nowhere. I think I simply became more present. Once I noticed that first few fortuitous moments, something in me reset to start catching the next one, and the one after that. Is It Magic, Or Is It Your Brain? The reason you start noticing tiny miracles once you look for them is a real neurological function called the reticular activating system, or RAS. This is a network in the brainstem that filters what reaches your conscious awareness based on telling your brain what matters. Humans want to be right, so we set that internal radar to collect evidence for whatever we already believe. Whatever you’re thinking about, you tend to see more of it. It’s the same reason you buy a red car and suddenly notice red cars everywhere. Some call this the Baader-Meinhof phenomenon, which is the sense that once you learn something new, it starts showing up constantly. It’s also known as the frequency illusion. What’s actually happening is selective attention. Your brain flags the new thing as important and starts seeing it more frequently. This is also called a cognitive bias. There aren’t more red cars, you just notice them more often. So it seems I’ve set my RAS for tiny miracles, and honestly, it’s been a lot of fun. Am I more supported by the Universe than I was before? Probably not. But I am noticing that I’m supported, and that is creating even more openness. That’s my new bias, and I’m sticking with it. What would shift for you if you felt supported by the Universe and started collecting evidence that it was true? We’re Always Collecting Evidence You always training your brain to notice whatever you expect, whether that expectation serves you or not. Some people wake up already braced for disappointment. They feel people let them down, life is hard, nobody appreciates them, and nothing works out. And their brain will faithfully collect evidence for exactly that, all day long. But you can train your RAS to find positive evidence just as easily. Someone holds the door. A favorite song comes on and you catch yourself singing along. A cashier is unexpectedly friendly. A friend texts at exactly the right moment. String enough of these together and they add up to something real. You shift into a more open, more supported way of moving through your days. My Experiment, and What Changed I didn’t set out to prove anything with this. I never expected the Universe to hand me this many signs in a few short weeks. But by the third or fourth one, I stopped being surprised and started paying attention on purpose. That’s exactly how the RAS is supposed to work. Once I actively looked for tiny miracles, I found more of them. One day last week I realized I’d woken up happy and stayed that way straight through until bedtime. That was new for me. I’m usually quick to spot whatever’s annoying me. Something is shifting. If you’re over 50, you’re likely to notice this kind of thing more than a younger person would, simply because you’ve spent decades reading rooms, situations, and people. Your brain has stopped needing raw data to make sense of a moment and started leaning on pattern, context, and vibe instead. What can feel like sudden intuition can be your brain matching this moment against thousands of moments you’ve already lived. That’s what I mean when I talk about midlife magic . It only comes with the miles, and with those miles comes a deeper appreciation for the little stuff that goes right. What If the Magic Doesn’t Show Up? If you go looking for tiny miracles and nothing shifts, that’s not a sign you’re doing something wrong. More often, it’s a sign something is in the way. Many of us carry a protective heart wall, built from grief, disappointment, or old self-protection. Unfortunately, that can unconsciously block what tiny miracles need to get through, without you ever knowing it’s there. That’s exactly what I’m addressing at a live Heart Wall Releasing event on July 29th, from 10–11:30am ET. It’s a gentle, remarkably effective meditation process. And it’s safe because your own inner wisdom guides the entire experience. The investment is just $22, and I’m keeping the group small — limited to 10 women, with a few spots already claimed. If you’ve been wondering whether a heart wall might be dimming your magic or getting in the way of something you desire, I’d love to guide you through it. Register now to grab your spot. FAQ: Tiny Miracles – How to Start Noticing Yours What is a tiny miracle? A tiny miracle is a small, everyday moment of kindness, timing, or connection — a stranger’s compliment, a found coin, a call that arrives right on cue — that feels like more than chance and leaves you a little lighter. Why am I suddenly noticing more good things happening to me? Once your brain flags something as meaningful, your reticular activating system (RAS) starts surfacing more of it in your awareness. You’re not attracting more good moments; you’re finally catching the ones that were already there. What is the reticular activating system (RAS)? The RAS is a network in the brainstem that filters incoming information and decides what reaches your conscious attention, based largely on what you’ve told it matters. What is the Baader-Meinhof phenomenon? Also called the frequency illusion, it’s the experience of suddenly noticing something everywhere right after you first become aware of it — like seeing red cars everywhere after buying one. What is a heart wall, and how does it relate to noticing magic? A heart wall is a protective barrier around the heart, often built from grief, disappointment, or self-protection, that can block the openness needed to notice tiny miracles or invite in what you desire. Key Takeaways – Where IS the Magic in All This? Tiny miracles aren’t new; they’re likely happening around you already, and most get missed in the rush of a normal day. Your reticular activating system will collect evidence for whatever you focus on, positive or negative, so choosing what to look for actually matters. Noticing one tiny miracle tends to open the door to noticing the next one. If the magic isn’t showing up for you lately, that’s not a personal failing. It may point to a heart wall quietly getting in the way. The live Heart Wall Releasing event is July 29th, 10–11:30am ET, $22, 8 spots remain  Register Here { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is a tiny miracle?", "acceptedAnswer": { "@type": "Answer", "text": "A tiny miracle is a small, everyday moment of kindness, timing, or connection that feels like more than coincidence. Examples include a stranger's compliment, a found coin, or a call that arrives at exactly the right moment. On their own these moments seem minor, but noticed together they shift how supported life feels." } }, { "@type": "Question", "name": "Why am I suddenly noticing more good things happening to me?", "acceptedAnswer": { "@type": "Answer", "text": "Once the brain flags something as meaningful, the reticular activating system begins surfacing more of it in conscious awareness. This means good moments were likely already occurring; the shift is in what's finally being noticed, not in the Universe suddenly producing more of them." } }, { "@type": "Question", "name": "What is the reticular activating system (RAS)?", "acceptedAnswer": { "@type": "Answer", "text": "The reticular activating system, or RAS, is a network in the brainstem that filters incoming information and determines what reaches conscious attention. It prioritizes information based on what has already been identified as important, which is why focused attention tends to produce more of what a person is looking for." } }, { "@type": "Question", "name": "What is the Baader-Meinhof phenomenon?", "acceptedAnswer": { "@type": "Answer", "text": "The Baader-Meinhof phenomenon, also called the frequency illusion, is the experience of suddenly noticing something everywhere shortly after first becoming aware of it. A common example is noticing a particular car model constantly after buying one. It reflects selective attention rather than an actual increase in frequency." } }, { "@type": "Question", "name": "What is a heart wall, and how does it relate to noticing magic?", "acceptedAnswer": { "@type": "Answer", "text": "A heart wall is a protective barrier around the heart that can form from grief, disappointment, or self-protection. It can quietly block the openness needed to notice tiny miracles or invite in what's desired, often without the person realizing the barrier is there." } } ] } The post Tiny Miracles Happen Every Day But It’s Up To You To Notice appeared first on Intuitive Edge.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil-‘Alameen. Wa salātu wa salāmu ‘alā ash-sharafi al-anbiyā’ wa al-mursaleen, Muḥammadur Rasūlullāh ﷺ, wa ‘alā ālihi wa sahbihi ṣallam. Tasleeman takhtirun kathira. I’m Abadu, my brothers and sisters. The ultimate reason that people like to accumulate or want to accumulate wealth, the final, ultimate reason, the biggest thrill, the… Continue reading How to become influential

Marcelo Shei, owner of Altamar Sistemos Aquáticos, discussed his extensive experience in the RAS industry in Brazil and Latin America. He highlighted major projects with marine species, including Genomar's tilapia genetics facility. He also shares his work as president of the World Aquaculture Society's Latin America and Caribbean chapter and translating the Yellow Book of Recirculating Aquaculture in Portuguese.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alḥamdulil-lāhi Rabbil-‘Ālamīn. Wa salātu wa salāmu ‘alā ash-sharafi al-anbiyā’ wal-mursalīn, Muḥammadin Rasūlallāh ṣallallāhu ‘alayhi wa ‘alā ālihi wa sahbihī wa sallam. Tasleeman kathīran kathīra, khamma ba’duh. Now, brothers and sisters, we are talking about the issue of belief, *Imān bil-Ghaib*, belief in the Akhīrah, and how that is the fundamental… Continue reading Belief in Al-Ghayb – #3

Rock Thomas is a serial entrepreneur, motivational speaker, and personal development teacher whose 7.5-minute story about his father has been viewed by over 125 million people and credited with changing thousands of lives. The youngest of seven kids raised on a farm by a cold, duty-bound father, he channeled that pain into decades of overachievement before spending over $2 million on his own healing and building a body of work on breaking generational trauma. This episode gets into what happens when a boy grows up chasing a father's approval that never comes, and how that wound quietly shapes marriage, friendship, and the way you show up as a dad. If you are a father wrestling with your own childhood, questioning whether you're doing a good job, or trying to break a cycle you inherited, this conversation will hit home.   Timeline Summary [1:02] – Larry shares how a coach showed him Rock's video at the Dad Edge Summit and it moved him to tears [2:14] – Rock explains how his 7.5-minute story with Goal Cast reached 125 million people and stopped people from taking their lives [3:00] – The origin of the wound: a young boy craving a distant German father's approval [4:20] – Broken arm, "suck it up," and the trauma that drove decades of overworking [5:16] – Why Rock reframes the David Goggins "stay hard" model as pain in disguise [6:08] – The empty, hollow heart behind the boats, cars, and houses [7:07] – Rock's mission to be the one who breaks the generational cycle [7:28] – The football day: waking up excited, and the moment his spirit broke [9:53] – Larry describes his own absent father and running into him in a coffee shop at 30 [12:06] – Larry's vow to play with his kids 300 days a year after watching Rock's video [18:22] – How the father wound showed up in Rock's friendships and marriages through self-sabotage [23:00] – The hockey parking lot: leaving before the other kids to please his father [24:14] – Why Rock spent over $2 million on therapy, mentors, and personal development [28:52] – The real win isn't the home run, it's a dad in the stands saying "that's my boy" [30:25] – Larry shows a video of his 17-year-old son and the dad he's becoming [33:12] – Rock on the ego, the amygdala, and the voice of doubt keeping men stuck [35:07] – The "I used to... but now" method for rewiring your identity one small shift at a time [42:26] – Why big hairy goals backfire and how tiny wins harness dopamine and the RAS   5 Key Takeaways Kids Want Connection, Not Trophies — Overachievement can look like success while masking an empty heart. What children actually crave is to be seen, felt, and heard, not provided for from a distance. The Wound Shapes Every Relationship — An unhealed father wound quietly leaks into marriage and friendship through self-sabotage and distrust. Naming the pattern is the first step to stopping it. Break the Cycle On Purpose — You can be the one person in your family line who chooses differently. Doing the work now means your kids inherit the healing instead of the wound. Change Your Identity One "I Used To" At a Time — When a negative thought surfaces, catch it and say "I used to... but now" followed by a tiny new action. Small wins trigger dopamine and reprogram your subconscious over time. Small Goals Beat Big Hairy Goals — Massive goals trip your survival brain into fear of failure. Micro-commitments slip past that alarm and let your reticular activating system pull you toward the person you want to be.   Links & Resources Podcast Shownotes — https://thedadedge.com/1502 The Dad Edge Alliance — https://thedadedge.com/join The Dad Edge Business Boardroom Brotherhood — https://thedadedge.com/goals   Enjoyed This Episode? If Rock's story about that one football morning hit you the way it hit Larry, don't keep it to yourself. Text this episode to a dad who's carrying his own father wound, or to a friend who's chasing approval he'll never get. And if this show keeps showing up for you, follow, rate, and leave a review so more fathers can find it.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alḥamdulilāhi Rabbil-ʿĀlamīn. Wa salātu wa salāmu ʿalā ash-sharafi al-anbiyāʾi wal-mursalīn. Muḥammadur Rasūlullāh ṣallallāhu ʿalayhi wa ʿalā ālihi wa sallam. We were talking about the fundamental principle in Islam, which is Iman bil-Ghaib—the belief in the unperceivable. And we believe not because we have seen, nor because we have experienced, but… Continue reading Belief in Al-Ghayb – #2

Opie kicks things off by admitting he banged two of his RAs in college, then Erik Marino pops on looking like young Santa Nick and shares his nightmare RA who smelled like explosive Indian food. The gang spirals into Trump flying with a national-security poop suitcase, the wildest penis crime story ever (Bobbitt who?), arcade game nostalgia (Jumper = Mario!), 1830s Americans drinking 7 gallons of ethanol a year, and nonstop unhinged banter. Pure Opie Radio mayhem with Ron the Waiter — zero filter, maximum laughs. You don't want to miss this one.Donating to the show helps us make more! PayPal - opieradiohttps://www.paypal.com/ncp/payment/JANCGHFW7GJHA

Au Liban, la guerre ne se joue pas seulement sur terre. Elle se poursuit aussi en mer. À Tyr, l'un des principaux ports de pêche du pays, les bateaux restent amarrés. À la frontière, le port de Naqoura a été détruit. Ailleurs, des pêcheurs ont été arrêtés ou pris pour cible, et les zones de pêche sont désormais drastiquement réduites. Selon la FAO, le secteur de la pêche et de l'aquaculture a déjà perdu 6,3 millions de dollars depuis le début de la guerre.  De notre envoyée spéciale à Tyr, Amélie David Au Liban, le port de pêche de Tyr est calme en cette fin juin. Une majorité des pêcheurs sont à quai, réparant leurs filets et leurs bateaux, comme Maroun Khoury et son père. Pour eux, le cessez-le-feu n'a rien changé : « Honnêtement, la situation est un peu difficile pour les pêcheurs. Avant, il y avait des zones plus au sud où ils pouvaient aller pêcher. Maintenant… il y a seulement deux jours, par exemple, un bateau s'est rendu là-bas. Il est allé assez loin, mais ils ont été interrogés et contraints de s'arrêter. Désormais, nous sommes limités à des zones de pêche situées à proximité. » Chez les Khoury, on est pêcheur de père en fils. Mais Maroun, 19 ans, n'a jamais connu une mer aussi inaccessible. « Si vous divisez tout entre nous : chaque personne sur le bateau gagne autour de 10 dollars par jour. 10 dollars après avoir payé le diesel. La mer ne vous rend pas riche. Vous gagnez juste assez pour manger. » Sur le port, les bateaux sont plus nombreux que les hommes en mer. Autour d'un café, ceux qui ne sortent plus attendent des jours meilleurs. Seule une quarantaine d'entre eux continuent aujourd'hui à prendre la mer. Selon le vice-président du syndicat des pêcheurs du sud, Sami Rezze : « Maintenant, nous ne sommes pas autorisés à pêcher entre Ras al-Ain et Rashidieh (au sud de Tyr, près de la frontière avec Israël. Et les pêcheurs ne peuvent toujours pas pêcher 24 heures sur 24. Il y a des heures spéciales pendant lesquelles nous avons le droit de sortir. La zone de pêche s'étend sur environ trois kilomètres au sud de Tyr. » Aux restrictions imposées, semblables à celles en place pendant l'occupation par Israël du sud du Liban dans les années 1980, s'ajoutent les menaces et la peur : « Si un pêcheur dépasse la limite autorisée, les patrouilleurs israéliens ouvrent le feu sur lui. Les drones le repèrent immédiatement. Que sommes-nous censés faire ? Avant-hier encore, des patrouilleurs israéliens ont poursuivi un bateau de pêche jusqu'à Tyr, tout en tirant dans sa direction. Les drones sont présents tous les jours. Ils ne laissent jamais les pêcheurs tranquilles. Les petits drones de surveillance tournent constamment au-dessus de leurs têtes, suivant chacun de leurs mouvements. » Dans le café du port, les pêcheurs font passer le temps en jouant aux cartes. Pour Radwan, pêcheur depuis plus de 20 ans, la guerre n'est pas la seule menace. Surpêche, pêche à la dynamite, réchauffement de la Méditerranée... Les poissons se raréfient, déplore-t-il, et les causes sont nombreuses. Dans le port de Tyr, les filets continuent d'être réparés chaque matin. Mais tant que la guerre imposera ses frontières en mer, c'est surtout l'attente que les pêcheurs ramèneront dans leurs filets. À lire aussiLiban: à Tibnine, sous le bourdonnement des drones israéliens, une paix toujours hors de portée

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alḥamdulilāhi Rabbil-‘Ālamīn. Wa salātu wa salāmum ‘alā al-sharafi al-anbiyā’ wal-mursalīn, Muḥammadin Rasūlallāh ṣallallāhu ‘alayhi wa ‘alā ālihi wa sahbihi wa sallam. Taslīman kāseran kāseran. Ma’ma ba’du. My brothers and sisters, I was thinking the Imam, may Allah bless him, recited the second āyah from Surah Az-Zariyāt. And especially this āyah… Continue reading What should we worry about

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil-‘Alameen. Wa salātu wa salāmum ‘alā ashrafil anbiyā’ wal mursalin. Muḥammadur Rasūlullāh ṣallallahu ‘alayhi wa ‘ala alihi wa sahbihis-salam. Tasliman kathīran kathīran. My brothers and sisters, today one of the most dominant phenomena in the world is social media. And if you think about it, the simplest description of… Continue reading Advice from the Stoics

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil-‘Alameen. Wa salātu wa salāmum ‘alā ash-sharafi al-anbiyā’ wal-mursalīn, Muḥammadin Rasūlallāh sallallāhu ‘alayhi wa ‘alā ālihi wa sahbihi wa sallam. Tasliman kathīran kathīrān. Muhammadu, my brothers and sisters, Imam Ibn Taymiyyah rahimahullāh ta’ālā, he is reported to have said that there is nothing which is a more powerful cure… Continue reading Food for the soul

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alḥamdulilāhi Rabbil-‘Alāmīn. Wa salātu wa salāmu ‘alā ashrafil-anbiyā’ wal-mursalīn. Muḥammadur Rasūlullāh ṣallallāhu ‘alayhi wa ‘alā ālihi wa sahbihī wa sallam. Tasliman kathīran kathīrān. Muḥammadur Rasūlullāh ṣallallāhu ‘alayhi wa sallam. My brothers and sisters, we are on our subject of approaching the Qur’ān al-Karīm in the way that Rasūlullāh ṣallallāhu ‘alayhi… Continue reading Reflection is not speculation

Kope futbalovou loptou do golfových jamiek, na svetových šampionátoch necháva za sebou absolútnu elitu a cez týždeň zapisuje známky do EduPage. Lucia Čermáková je unikátnym zjavom slovenského športu. Dvojnásobná majsterka sveta vo footgolfe prijala pozvanie do podcastu suSPEAK na ŠPORT.sk, kde moderátorom Rasťovi Konečnému a Marekovi Marušiakovi porozprávala nielen o svojej ceste na svetový trón, ale aj o úsmevných paradoxoch, ktoré tento dynamicky sa rozvíjajúci šport prináša.Obhájiť najcennejší kov je v športe vždy ťažšie ako ho získať prvýkrát. Lucii Čermákovej sa to však podarilo v mimoriadne extrémnych podmienkach na šampionáte v Mexiku, kde hráči bojovali s horúčavami okolo 40 stupňov a takmer stopercentnou vlhkosťou vzduchu. O fyzickej náročnosti svedčí aj fakt, že počas dvanástich dní turnaja nachodila neuveriteľných 300-tisíc krokov.V rozhovore otvorene opisuje, ako vyzerá psychická a fyzická príprava na šport, ktorý je v prvom rade hrou v hlave. „Mám šťastie, že si viem zachovať chladnú hlavu počas celej hry. Aj keď sa mi niečo nepodarí, poviem si: ‚dobre, máš ďalšiu jamku na to, aby si to napravila',” prezrádza v podcaste recept na úspech, ktorý z nej spravil nočnú moru pre súperky z celého sveta.Poslucháčov určite zaujme detailný pohľad na footgolfové vybavenie a prísnu golfovú etiketu. Hráči musia dodržiavať dress code s golierikmi a miesto kopačiek obúvajú len turfy.Najväčším pokladom každej hviezdy je však správna lopta. Lucia Čermáková prezrádza, že jej tajnou zbraňou sú legendárne lopty Jabulani z majstrovstiev sveta vo futbale v roku 2010, ktoré majú špecifickú váhu a letovú trajektóriu, no dnes sú na trhu doslova podpultovým tovarom s obrovskou hodnotou.O to kontrastnejšie pôsobí finančná realita tohto športu. Keď sa moderátori pýtali na odmenu za svetový titul z Orlanda, odpoveď ich šokovala. „Bola to finančná odmena 700 eur, ktorú sme dostali ako kredit na ďalšie štartovné,” hovorí s úsmevom sympatická slovenská reprezentantka, čím dokazuje, že footgolf sa na Slovensku hrá predovšetkým z čistej lásky k športu.V bežnom živote je Lucia Čermáková obľúbenou učiteľkou telesnej výchovy a informatiky na základnej škole, kde medzi žiakmi po zisku medailí požíva status doslovnej športovej bohyne. V podcaste sa dozviete, ako dopadol jej experiment, keď si na jeden deň vyskúšala rolu riaditeľky školy a zistila, čo všetko zahŕňa riadenie pedagogického zboru.Keďže v štúdiu sedela oproti hokejistom, došlo aj na prekvapivé športové priznanie z jej detstva, kedy sama hrávala hokej s chlapcami. Dnes si síce zápasy pozrie, no najviac ju priťahuje tvrdá hra. „Mám rada hokej, ale najviac mám rada, keď sa bijú. Keď sa rozkrikujú a čakajú len na to, tak hneď pozerám,” smeje sa Lucia Čermáková v uvoľnenej debate.Najnovšia epizóda podcastu suSPEAK na ŠPORT.sk prináša mimoriadne pútavý, vtipný a inšpiratívny pohľad do sveta športu, o ktorom ste možno doteraz vedeli len málo, no po vypočutí tohto rozhovoru dostanete okamžitú chuť vybehnúť na „grín”. Pustite si celú epizódu a spoznajte osobnosť, ktorá robí Slovensku to najlepšie meno na svetovej mape.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Al-ḥamdu lillāhi Rabbil-‘Alāmīn. As-salātu was-salāmu ‘ala ash-sharafi al-anbiyā’ wal-mursalīn. Muḥammadur Rasūlullāh ṣallallāhu ‘alayhi wa ‘alā ‘ālīhi wa saḥbihī wa sallam. Taslīman kathīran kathirahum ‘abaduh. My brothers and sisters, we are talking about the importance of the Qur’ān al-Karīm, which Allāh subḥānahū wa ta’ālā blessed us with and revealed to us.… Continue reading Reflect and live by the Qur’an

Au Venezuela, plus d'une semaine après le double séisme, un homme a été retiré vivant des décombres ce jeudi (2 juillet 2026). Un véritable miracle, alors qu'il y a de moins en moins d'espoir de signes de vie après ce drame qui a fait plus de 2 500 morts et des dizaines de milliers de disparus dans le nord du pays. À ce bilan, il faut ajouter les déplacés qui ont tout perdu. Certains se sont réfugiés dans un stade de La Guaira où se sont rendus nos envoyés spéciaux, Mélissa Barra et Jad El Khoury. L'une des priorités des organisations humanitaires est d'apporter un soutien psychologique aux enfants. La colère gronde toujours au sein de la population, explique, pour sa part, Alice Campaignolle, correspondante de RFI à Caracas. Beaucoup considèrent le gouvernement responsable du retard des secours et de la gestion chaotique de la crise. Dans la zone la plus touchée, « les altercations entre survivants et forces de l'ordre se multiplient, les habitants trouvent que les fonctionnaires de police ou les militaires n'en font pas assez, qu'ils devraient être comme eux, sur les décombres, à chercher des survivants ou bien maintenant à extraire les corps », raconte la journaliste. Une colère qui se double d'une grande méfiance envers Delcy Rodriguez, héritière de Nicolas Maduro. Avant ce drame, beaucoup de Vénézuéliens réclamaient des élections libres. Les habitants veulent changer de gouvernement, notamment à cause de la corruption qui ronge tous les services de l'État. Aujourd'hui, une bonne partie de la population refuse de remettre des dons « à des fonctionnaires de peur qu'ils ne soient pas volés. Les gens n'acceptent pas non plus que la police les empêche de circuler sur la zone sinistrée, convaincus que c'est pour cacher quelque chose. Des mesures qui sont parfois importantes pour la sécurité, se retrouvent questionnées, à cause de cette cassure entre le peuple vénézuélien et ses dirigeants et les forces de l'ordre », analyse Alice Campaignolle.   En Colombie, une transition houleuse La Colombie connaît actuellement une période politique tendue. Le nouveau président d'extrême droite, le millionnaire Abelardo de la Espriella élu le 21 juin 2026 ne prendra ses fonctions que le 7 août. D'ici là, son équipe et l'exécutif sortant sont engagés dans un processus de transition compliquée. Les deux camps multiplient les attaques et les déclarations tonitruantes, nous explique Marine de La Moissonnière du service international de RFI.   Haïti : la ville de Marchand-Dessalines sous l'emprise de Kokorat san Ras depuis deux mois Depuis leur installation dans cette ville historique du département de l'Artibonite, les membres du gang Kokorat san Ras imposent leur loi. En mai 2026, après la démolition du commissariat de la commune, ils sont devenus les seuls maîtres des lieux. Prise en otage, la population tente désormais de survivre entre peur, silence et manque de protection. Un reportage de Ronel Paul.   Le journal de la 1ère À la Une : le Plan Sargasses 3.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil-‘Alameen. Wa salātu wa salāmu ‘alā ashrafil-anbiyā’ wal-mursalīn, Muḥammadin Rasūlullāh ṣallallāhu ‘alayhi wa ‘alā ālihi wa sahbihī wa sallam. Tasliman kathīran kathīrān. Wa amma ba’du, my brothers and sisters, we continue with our discussion on free thinking in the Qur’an. And I remind myself and you that the Kalam… Continue reading Respect is a condition of guidance

In this episode of Roompact's RA*EdChat, we go behind the scenes of residence life to explore how strong staff relationships shape the RA experience. “Behind the Scenes: Working With Your Team” dives into collaboration, communication, and peer support, highlighting how successful communities are built not just through resident connections but through trust and teamwork among staff members. We meet with Katelyn Neeley, a community director who shares knowledge and personal experience on the topic, as well as advice for RAs. 

What if the real threat of AI isn't that it replaces your job — but that it slowly replaces you? In this electrifying episode of The Brain Vault Podcast, Larry sits down with Derek Rydall — bestselling author, founder of the Whole New Human Movement, and host of the globally recognized Emergence podcast — for one of the most expansive conversations we've ever had about human potential, identity, and what we're really here to become. After a near-death experience shattered his understanding of success, Derek spent decades bridging ancient wisdom with modern neuroscience to answer one question: what makes us truly irreplaceable? In this episode, you'll hear: Why AI is the greatest existential crisis and the greatest evolutionary opportunity we've ever faced What the ancient Sanskrit meaning of "human" reveals about who you actually are How the Oracle of Delphi's "Know thyself" was never an affirmation — it was a warning Why your conditions don't determine your destiny, but your character does The race car driver principle that explains why you keep hitting the same walls Why knowledge is not power — and what to do with it instead This conversation isn't just about surviving the AI revolution. It's about finally becoming who you were always meant to be. Connect with Derek at derekrydall.com and grab his book A Whole New Human on Amazon. ABOUT DEREK RYDALL Derek Rydall is the bestselling author of A Whole New Human, The Abundance Project, and Emergence. He is the founder of the Whole New Human Movement and the host of the globally recognized Emergence podcast. Derek bridges ancient wisdom and modern science, drawing on decades of study in psychology, neuroscience, spirituality, and creativity. His work has been forged through profound personal transformation, not theory alone. ABOUT LARRY OLSEN Larry Olsen is a Two-Time Vistage Speaker of the Year and Fortune 50/500 Executive Performance Advisor with 40+ years of client work at Toyota, PepsiCo, Starbucks, Harley-Davidson, Honda, American Airlines, State Farm, Frito Lay, Lexus, and Tropicana. He is the author of Get a Vision and Live It! and the founder of Performance Driven Neurology. IF THIS LANDED FOR YOU The next step is Larry's Brain Hacks Intensive. It is a guided practice that walks you through the foundational mindset shifts Larry teaches Fortune 500 executives. Brain Hacks Intensive: https://neuromindedcollective.com/brain-hacks-challenge CONNECT WITH LARRY Website: larryolsen.com LinkedIn: linkedin.com/in/larry-r-olsen CONNECT WITH DEREK RYDALL Website: DerekRydall.com YouTube: Legendary Life, Derek Rydall Podcast: Emergence Latest Book: A Whole New Human: 10 Ways We Must Evolve to Survive and Thrive in the AI Age SUBSCRIBE FOR MORE New episodes of the Brain Vault Podcast publish every other Wednesday. Yours in growth, Larry

Based on the provided transcript of the IPS DEPROGRAM from June 26, 2026, here is a breakdown of the session:The central theme of the session is the "Metascript," a framework for understanding how global events are manufactured, "history-bent," and coordinated through entertainment and news media to condition public consciousness. The speaker specifically uses the movie Citizen Vigilante and the alleged "squibbing" (faked death) of Charlie Kirk as case studies to demonstrate how predictive and concurrent programming are used to hijack the human brain's natural filtering systems."Citizen Vigilante" as Targeted Agitprop: The film is described as a "woke right Batman" story designed as an influence operation to fuel anti-immigrant sentiment and "White Lives Matter" martyrdom, perfectly timed with real-world "PsyOps" like the Henry Novak case.The Frequency Illusion (Red Car Theory): The speaker explains how predictive programming utilizes the Reticular Activating System (RAS) to prime the audience; once a concept is "top of mind," the brain filters for it, making future staged events seem obvious or inevitable.The Charlie Kirk "Simulation": The session asserts that Charlie Kirk's death was a drill involving crisis actors and "planted lines" (such as conflicting reports of heart vs. neck wounds) to create a martyr narrative that the political left would "froth at the mouth" over.Compartmentalization of Secrets: Addressing the "too many people to keep a secret" argument, the speaker posits that hoaxes like the moon landing or simulated mass shootings only require a few hundred "in the know" operatives, with the rest of the participants managed through compartmentalized security clearances.Media Triangulation and the Duopoly: Mainstream and alternative media are presented as a "pro-anti" duopoly that prevents true disbelief; by fighting over the details of an event, both sides inadvertently validate the event's reality.Engineered Mythos and One-World Religion: Using Steven Spielberg's work as an example, the speaker argues that the government is engineering a new religious paradigm (e.g., alien-angel synthesis) to condition humanity for a unified, AI-controlled global system."Predictive programming is designed to hijack our subconscious mind in every way... the RAS decides what's important what gets ignored.""The mainstream mediated worldview is in fact resting upon an edifice of lies.""I don't advocate for any belief systems here. We're talking about fomenting a culture of disbelievers—informed non-believers in the face of compulsive belief.""This is an influence operation that is coordinated in its release and the timing.""The triangulation... which is the fight over each event or each person, is the engagement that makes them real."In this IPS DEPROGRAM session, the speaker argues that the contemporary news cycle is a "house of cards" built on decades of simulated events and "history bending". By analyzing the film Citizen Vigilante, the speaker illustrates how predictive programming sensitizes specific demographics to respond to future "PsyOps". The session concludes by introducing the IPS Institute for Metascript Deconstruction, which aims to train "certified auto-hoaxers" to reject the "world stage" entirely and adopt an "off-world stage" perspective, treating both mainstream and conspiracy narratives as manufactured subplots of a singular control mechanism.Main Topic: The Metascript and Influence OperationsKey Points5 Key QuotesSummary

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events reshaping the landscape of this dynamic industry. Replimune has made headlines with the resubmission of its oncolytic virus-based immunotherapy, RP1, to the U.S. Food and Drug Administration for treating advanced melanoma. The FDA's acceptance after two prior rejections is significant, suggesting a shifting regulatory landscape that could favor innovative cancer therapies like oncolytic viruses. These therapies represent a novel approach to engage the immune system in targeting tumors, and if RP1 gains approval, it may open doors for similar treatments, potentially offering new hope for melanoma patients. On the regulatory side, Amgen has encountered challenges with Tavneos after losing European Union endorsement due to data integrity issues. This serves as a stark reminder of the critical importance of maintaining stringent data management throughout drug development. With an FDA hearing on the horizon, the implications are far-reaching, emphasizing increased scrutiny from regulatory bodies worldwide. This scenario could lead to more rigorous guidelines governing data practices in the future. The European Commission's approval of Henlius' Hetronifly as a first-line treatment for squamous non-small cell lung cancer marks a milestone in cancer immunotherapy. This approval highlights the ongoing efforts to improve patient outcomes through innovative PD-1 inhibitor-based combination therapies, showcasing progress in the fight against one of the most challenging forms of cancer. Epicrispr Biotechnologies brings promising news from its phase 1/2 trial of EPI-321, a gene therapy for facioscapulohumeral muscular dystrophy. The trial's success in enhancing muscle function through epigenetic silencing underscores significant advancements in gene therapy applications for neurological disorders. Similarly, Abbisko Therapeutics' phase 2 trial reports a 90% objective response rate using FGFR2/3 and PD-L1 inhibitors for gastric cancer, demonstrating the potential of targeted small molecule therapies in oncology. In financial developments, Definium Therapeutics and Ligachem Biosciences have made substantial funding strides to bolster their drug development pipelines. Definium's $805 million raise aims to advance psychiatric and neurological treatments, while Ligachem's funding will enhance its antibody-drug conjugate platforms. These investments reflect strong investor confidence in next-generation therapeutic platforms and underscore innovative financing strategies crucial for sustaining research and development efforts. Bayer's recent legal victory at the Supreme Court overturning a $1.25 million verdict related to its Roundup product is another focal point. This ruling not only positively impacts Bayer's financial standing but also highlights the complexities surrounding product liability cases within pharmaceuticals and agrochemicals. Strategically, Moderna has unveiled an ambitious R&D roadmap aiming for break-even by 2028 with over seven new products on the horizon. By focusing on mRNA vaccines for oncology and rare diseases, Moderna continues to leverage its technology beyond COVID-19 applications, potentially transforming treatment paradigms across various therapeutic areas. Shifting focus to industry trends, Sanofi finds itself under investigation by the European Commission for antitrust violations linked to its flu vaccine marketing practices. This situation underscores growing scrutiny over competitive practices within the pharmaceutical sector and could influence regulatory compliance strategies across global markets. In technological advancements, Eli Lilly is employing artificial intelligence to raise awareness about Alzheimer's disease through creative engagements like a European radio show road trip. These initiatives reflect an industry-wide shift towards technology-driven marketing strategies aimed at personalizing patient interactions. Lastly, Merck KGaA's $11 billion acquisition of Bio-Techne exemplifies a strategic move to enhance capabilities in immune cell therapy production. This deal underscores the growing importance of manufacturing innovations in bringing advanced therapies to market and highlights strategic collaborations increasingly seen across the sector. The landscape is further defined by significant scientific breakthroughs such as Revolution Medicines' development of a second RAS blocker, showing improved chemotherapy responses in pancreatic cancer patients. These advancements underscore the need for continued investment in targeted therapeutics research as they promise better patient outcomes and highlight ongoing innovation within oncology. As these developments unfold, they reflect an industry poised for transformation amid evolving scientific, regulatory, and market dynamics aimed at improving patient care globally. With these insights into current trends and future directions, it's clear that the pharmaceutical and biotech sectors are navigating a period rich with potential for groundbreaking advancements that will shape healthcare outcomes worldwide.Support the show

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil ‘Alameen. Wa salātu wa salāmu ala ashrafil anbiyā’ wal mursalīn. Muḥammadur Rasūlullāh sallallāhu alaihi wa ala alihi wa sahībuhum sallam. Tasliman kathīran kathīran. Hamd ba’du wa abradu. Alhamdulillah. Today we are fasting for the, on Yawm al-Ashrā. And Nabi Sallallāhu alaihi wa sallam said, the one who fasts… Continue reading Accountability is the key to success

Survivor Legend Jonny Fairplay is joined by Ben Orndorff from Netflix's new hit show Outlast The Jungle. Ben reveals what actual went down on the island and what his experience on the show was like. Get your questions read live with Ben!Special thanks to the best Whiskey on the Planet Watertown Whiskey! Check them out on instagram: https://www.instagram.com/watertownwhiskey/?hl=en Tell them Fairplay sent you! Use promo code SURVIVOR at checkout for Fairplay's discount! Please Drink Responsibly https://watertownwhiskey.com/Our new Website is live! Check it out at: www.realityaftershow.comCome play Celebrity Traitors with Jonny and his amazing reality star friends! Get tickets NOW at SurvivorTix.comCheck out my Twitch: twitch.tv/bobbygoodsbyJoin our Patreon at RealityPatron.comIf you would like a cameo from Jonny Fairplay order one now! cameo.com/jonnyfairplayCheck us out on Tiktok @fairplaytokGet your shirt JUST like Jonny Fairplay at fairplayshirts.com

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil-‘Alameen. Wa salātu wa salāmum ‘alā ash-sharafi al-anbiyā’ wal-mursalīn, Muḥammadin Rasūlullāh ﷺ, wa ‘alā ālihi wa sahbihī sallam. Tasliman kathīran kathīran fa mubādā’. My brothers and sisters, I mention to you and remind myself that we are all the creatures of Allah subḥānahū wa ta’ālā. We are all the… Continue reading Remember our death

In this episode, Shikha Jain, MD, speaks with Revolution Medicines' Alan Sandler, MD, about groundbreaking advancements with daraxonrasib and how these findings will continue to impact metastatic pancreatic cancer. Daraxonrasib (RMC-6236, Revolution Medicines) is an investigational, oral pan-RAS inhibitor in development for treatment of advanced solid tumors, including pancreatic ductal adenocarcinoma. ·       Why the RASolute 302 trial got a standing ovation at ASCO. 3:16 ·       What do you think changed scientifically to make this particular drug and its results possible? 6:12 ·       What does the multi-selective RAS inhibition of this drug mean, and how does it differ from other drugs? 10:23 ·       How would you recommend navigating the early access program (EAP) for patients and physicians who want this drug now? 13:13 ·       What excites you about the future of pancreatic cancer and RAS treatment? 14:18 ·       How can you imagine when these drugs will get into the hands of patients if we see good results? 17:28 We'd love to hear from you! Send your comments/questions to Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Jain on X: @ShikhaJainMD and on Instagram @shikhajainmd. Sandler can be reached via email at inquiries@revmed.com. Reference: ·        Wolpin BM, et al. LBA5. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. Jain and Sandler report no relevant financial disclosures.

Editors Note: Last night Jonny's Internet got knocked out by a lightning storm. So Abby is back today to pick where the left off in the Interview. Sorry to everyone for abrupt ending to the last podcast! Thanks again to Abby for being able to reschedule with us.Survivor Legend Jonny Fairplay is joined by Abby Chu from Netflix's new hit show Outlast The Jungle. Abby reveals what actual went down on the island and what her experience on the show was like. Get your questions read live with Abby!Special thanks to the best Whiskey on the Planet Watertown Whiskey! Check them out on instagram: https://www.instagram.com/watertownwhiskey/?hl=en Tell them Fairplay sent you! Use promo code SURVIVOR at checkout for Fairplay's discount! Please Drink Responsibly https://watertownwhiskey.com/Our new Website is live! Check it out at: www.realityaftershow.comCome play Celebrity Traitors with Jonny and his amazing reality star friends! Get tickets NOW at SurvivorTix.comCheck out my Twitch: twitch.tv/bobbygoodsbyJoin our Patreon at RealityPatron.comIf you would like a cameo from Jonny Fairplay order one now! cameo.com/jonnyfairplayCheck us out on Tiktok @fairplaytokGet your shirt JUST like Jonny Fairplay at fairplayshirts.com

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alḥamdulilāhi Rabbil-‘Alameen. Wa salātu wa salāmum ‘alā ash-shirāfi al-amiyyay wa al-mursaleen, Muḥammadin Rasūlullāh ṣallallāhu ‘alayhi wa ‘alā ālihi wa sallam. Tasleeman kathīran kathīran. Qur’ān, ba’du. My brothers and sisters, Allāh subḥānahu wa ta’ālā, in the first or second āyah of Surah Al-Ankabūt, Allāh subḥānahu wa ta’ālā said: *Ahasibannas ann yutrakuka… Continue reading Life is a test

In this episode of OncLive On Air, Zev A. Wainberg, MD, sat down with OncLive to discuss the rapidly evolving landscape of KRAS-directed therapy in pancreatic ductal adenocarcinoma (PDAC), from pan-RAS inhibition to KRAS G12D–specific strategies, and what the next several years of clinical investigation may look like for patients with this difficult-to-treat malignancy.   Wainberg is a professor of medicine at the David Geffen School of Medicine at UCLA, co-director of the UCLA GI Oncology Program, and medical director of the UCLA Pancreas Cancer Center, where he also serves as director of the Early Phase Clinical Research Program at the Jonsson Comprehensive Cancer Center. This content is a production of OncLive; this OncLive On Air podcast episode is supported by funding, however, content is produced and independently developed by OncLive

Episode 11 - In conversation with Geeta Vara, author of Ayurveda and Rasāyana, exploring Ayurveda, ageing well and why working with nature matters.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Big change can feel disorienting even when you know it's the right move — and there's actual neuroscience behind why. In this episode of It's Your Time, host Michelle Bourque breaks down neural transfer, the brain science explaining why the skills you built in one chapter of your life (career, relationships, leadership) are already wired to carry you into the next one. Michelle shares what she's learned firsthand while relocating from New York to Florida after two decades in medical device sales, plus a powerful reframe from a mentor on why "I don't have management experience" is almost never actually true. You'll learn about far transfer, the brain's negativity bias, and the reticular activating system (RAS) — and why noticing synchronicities might be more science than woo. If you're in any kind of transition — career change, identity shift, new chapter — this episode will help you see the evidence you already have that you're ready. Listen now, and join Michelle's email list for weekly real talk, practical tools, and behind-the-scenes updates: michellebourquecoaching.com/newsletter

Have you ever used the "Ostrich Approach" to a difficult relationship, hid from a hard conversation, and ended up winning 50 different imaginary arguments inside your own head?Welcome back to The Catholic Coaching Podcast! In Episode 301, Matt and Erin are diving deeper into our conflict resolution series. Last week, we introduced the PACE framework (Pause, Assume Goodwill, Clarify, Engage). But the big question is: What actually happens inside that very first step—the Pause? Sometimes we abuse the pause to stew in resentment, or we skip it entirely and react out of unregulated emotion. To fix this, we are introducing a powerful new tool in this episode: The FACE Framework.When anger shows up, it's easy to give it a bad rap. But drawing from St. Thomas Aquinas and Catechism #1767, we unpack how anger is actually a morally neutral, complex passion made of two hidden components: Sorrow and Hope.To process your anger cleanly before reason kicks in, you have to FACE it:F – Find the Sorrow: What is the good thing you love that you perceive is being threatened or harmed?A – Assess the Story: Is your narrative a court-of-law fact, or are you editorializing?C – Challenge the Narrative: What fruits are you getting from this story, and how could the opposite be true?E – Examine the Hope: What do you want your anger to actually accomplish? (Restoring justice vs. seeking punishment).We walk through a highly relatable "Odd Couple" college roommate scenario featuring Brian (a highly ordered Melancholic) and Andy (a carefree Sanguine) to show RAs, ministry leaders, and coaches exactly how to accompany someone through a heated moment without falling into "story fondling."Whether you're dealing with a difficult coworker, a spouse, or navigating campus ministry, learning to purify your anger will completely transform your relationships.Send us Fan MailSupport the show____________________► Make sure to SUBSCRIBE to the Metanoia Catholic YouTube Channel!► Discover How God Is Speaking to You In Prayer► Find out your temperament: Take the Free Quiz► Get the Conversation Starter Guide (FREE) ► Take the Quiz: WHAT TYPE OF COACH ARE YOU?► GET THE DAILY SEVEN JOURNAL!This interactive journal will help you transform your life from the inside out by teaching you how to grow in gratitude, set healthy goals, and gain mastery over your thoughts.► JOIN THE ACADEMY!Your online resource of classes, tools, and community to ramp up your growth and really change your life. Learn from the Metanoia Catholic coaches in webinars, live coaching calls, Lectio Divina, and more with your monthly membership.____________________► SUB...

Why do high-performing men lose their identity in midlife? After 35 years on the front lines of emergency medicine and over 170,000 patients treated, Dr. Kenneth Ro stepped back and named something he was seeing repeatedly. The men coming through his ER weren't just breaking down physically. They were losing their identity, their edge, and their sense of purpose. In this conversation, Larry Olsen sits down with Dr. Ro to talk about what happens when a man's identity gets fused to his profession, and what to do about it before it costs him his health, his relationships, or his career. What you'll hear: • The Triple Caretaker Effect and why most men get the order wrong • Why "midlife crisis" is the wrong frame and what Dr. Ro calls a midlife inflection point • The Stephen Covey line that most leaders have heard but very few apply: climbing the ladder against the wrong wall • Dr. Ro on why silence is a bigger health risk factor than blood pressure or cholesterol • What happens when I've attached who I am to what I do? ABOUT DR. KENNETH RO Dr. Kenneth Ro is a double board certified emergency physician with 35+ years on the front lines of emergency medicine and over 170,000 patients treated. He is the author of Prime: How to Win the Second Half of Life and the founder of the Reclaim Method, a framework helping high-performing men in midlife rebuild their health, clarity, and confidence. Dr. Ro practices in Cypress, Texas. ABOUT LARRY OLSEN Larry Olsen is a Two-Time Vistage Speaker of the Year and Fortune 50/500 Executive Performance Advisor with 40+ years of client work at Toyota, PepsiCo, Starbucks, Harley-Davidson, Honda, American Airlines, State Farm, Frito Lay, Lexus, and Tropicana. He is the author of Get a Vision and Live It! and the founder of Performance Driven Neurology. IF THIS LANDED FOR YOU The next step is Larry's Brain Hacks Intensive. It is a guided practice that walks you through the foundational mindset shifts Larry teaches Fortune 500 executives. Brain Hacks Intensive: https://neuromindedcollective.com/brain-hacks-challenge CONNECT WITH LARRY Website: larryolsen.com LinkedIn: linkedin.com/in/larry-r-olsen CONNECT WITH DR. KENNETH RO Website: kennethromd.com Book: Prime: How to Win the Second Half of Life (Amazon, search Ken Ro MD) SUBSCRIBE FOR MORE New episodes of the Brain Vault Podcast publish every other Wednesday. Yours in growth, Larry

Joining the Project Purple Podcast is Andrew Waters, PhD, Assistant Professor of Medical Surgical Oncology at the University of Cincinnati. Dr. Waters joins host Dino Verrelli to discuss his lab's recent research recovery grant from Project Purple and his journey into pancreatic cancer research. Dr. Waters discusses the critical role of KRAS mutations that are found in about 93-94% of pancreatic cancer cases. KRAS and RAS-targeted therapies have evolved from being considered “undruggable” to becoming one of the most exciting and progressive areas in cancer treatment. Recent clinical breakthroughs include promising results from RevMed's investigational drug Daraxonrasib, which targets multiple KRAS mutations and has demonstrated early trial outcomes. We learn about the challenges that remain in pancreatic cancer research, including complex FDA approvals and access to use. Dr. Waters highlights his lab's research into how pancreatic cancer cells develop resistance to KRAS inhibitors by leveraging related proteins such as HRAS. NRAS and MRAS. Understanding these mechanisms could help researchers develop therapies and improve treatment durability and patient outcomes. Subscribe to the Project Purple Podcast for more stories from the pancreatic cancer community! You can learn more about Waters lab at https://med.uc.edu/depart/cancer-biology/labs/waters-laboratory. To learn more or donate to Project Purple's mission of a world without pancreatic cancer, visit projectpurple.org.

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm, al-ḥamdu lillāhi rabbil-‘ālamīn, wa-salātu was-salām ‘ala ash-sharafi al-anbiyā’ wal-mursalīn, Muḥammadur Rasūlullāh sallallāhu ‘alayhi wa ‘alā ālihi wa sahbihi wa-sallam, taslīman kathīran kathīran. Amma ba’du, my brothers and sisters, Allāh subḥānahu wa ta’ālā is the One who controls everything, wa huwa ‘alā kulli shay’in qadīr. Allāh subḥānahu wa ta’ālā is Qadīr… Continue reading Be pleased with Allahﷻ’s decree

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm, wa raḥmatullāhi rabbil ‘alameen, wa salātu wa salāmu ‘ala ashrafil anbiyā’ wal mursaleen, Muḥammadun Rasūlullāh sallallāhu ‘alayhi wa ‘ala ālihi wa sahhayhi, tasliman kathīran kathīran. My brothers and sisters, a young man came to Rasūlullāh sallallāhu ‘alayhi wa sallam, and he said to him, “Ya Rasūlullāh sallallāhu ‘alayhi wa sallam,… Continue reading Small but powerful dua

Auto-generated transcript: Bismillāh ar-Raḥmān ar-Raḥīm. Alhamdulillāhi Rabbil ‘Alāmīn. Wa salātu wa salāmu ‘alā sharifin anbiyā’ wal mursalīn, Muḥammadun Rasūlullāh sallallāhu ‘alayhi wa ‘alā ālihi wa sahbihī wa sallam. Tasleeman kathīran kathīra. Fama ba’du. My brothers and sisters, we have been talking about since yesterday regarding the issue of what happens when Allāh protects us and… Continue reading Don’t despair of the mercy of Allahﷻ – Part 2

We're dropping this bonus episode because something genuinely historic happened in oncology and we couldn't wait until our regular schedule to talk about it. Dr. Mark Lewis, GI medical oncologist, pancreatic cancer survivor, and one of our absolute favorite guests. He just got back from ASCO, the Super Bowl of oncology, where a new drug called daraxonrasib received one of only about six standing ovations in the conference's history, including applause that broke out mid-sentence when researchers showed the survival data on-screen. The drug targets a mutation that drives the vast majority of pancreatic cancer and has been considered "undruggable" for decades and it works not by attacking the mutation directly, but by cutting off the downstream signals it sends, like snipping the wire instead of fighting with the switch. The results are remarkable. In patients who had already received standard chemotherapy, daraxonrasib roughly doubled survival time and delivered it in pill form rather than an IV every two weeks, a meaningful quality-of-life difference for people who are already facing the hardest year of their lives. Mark walks us through the science, the side effects (rash, because RAS proteins live in skin too), the path to FDA approval, and what this means beyond pancreatic cancer, the same KRAS mutations show up in about 30% of lung cancers and 40% of colon cancers. Takeaways: Pancreatic cancer has been devastatingly hard to treat, 85% of patients are incurable at diagnosis because it spreads silently and there's no good screening, leaving most patients with a median survival of about a year on IV chemotherapy. KRAS, the mutation driving nearly all pancreatic cancer, was long considered "undruggable", the protein was so smooth and spherical that no drug could bind to it, and researchers were actively discouraged from pursuing it as a target. Daraxonrasib works by cutting the power rather than fighting the switch, instead of binding to the KRAS protein itself, it uses molecular glue to interrupt the downstream growth signals the mutation sends, an approach that took decades to develop and wasn't taken seriously until now. The trial results roughly doubled survival and the treatment is a daily pill, not an IV, patients who had already been treated with chemotherapy gained approximately an additional year of life with improved quality of life, which represents one of the most significant advances in pancreatic cancer treatment in decades. This breakthrough has implications far beyond the pancreas, KRAS mutations drive about 30% of lung cancers and 40% of colon cancers too, and proving the target is druggable opens the door to a new generation of treatments across multiple cancer types. Want more Dr. Mark Lewis? X: @marklewismd To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices